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61. Introduction
These guidelines were developed from the Community Detoxification Protocols (Ana 
Liffey Drug Project, 2011) which were reviewed and amended in 2015. The purpose 
of these guidelines is to advise on the detoxification of service users in a community 
setting. The recommendations contained in these guidelines were developed by an 
expert multi-disciplinary team from within the addiction sector while also taking into 
consideration the available literature. This document provides support for the treatment 
of service users who are undergoing detoxification for benzodiazepine dependence. 
These guidelines are intended to be read by those involved in providing psychosocial 
and medical support for detoxification in a non-residential treatment setting. These 
guidelines outline the minimum medical and psychosocial supports which should be 
provided to an individual engaging in Community Detoxification. 
1.1 Aims
These guidelines aim to:
• reduce variation in practice and improve the quality of treatment decisions;
• provide professionals with structure and support to improve treatment outcomes;
• ensure that community-based detoxes have a medical and psychosocial support 
structure;
• educate health care professionals on the accessibility of community based 
detoxification;
• deliver a convenient treatment option to service users in all areas of the country.
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82. What is Community 
Detoxification?
Community Detoxification supports service users to reduce or stop their use of 
methadone, benzodiazepines or Z hypnotics through an organised process involving 
key workers and GPs within their community. It can be accessed as an alternative 
option to inpatient residential detoxification, or as a necessary step towards meeting 
entry requirements for residential treatment. There are three distinct Community 
Detoxification Guideline documents for: methadone; benzodiazepines; and Z hypnotics. 
While commonalities in the minimum standards of supports exist, there are important 
differences in the provision of detoxification options that are addressed in the guidelines, 
including: entry and exit criteria; detoxification schedules; and withdrawal symptoms. 
This document contains the benzodiazepine guidelines. 
These guidelines have been developed by an expert Steering Committee consisting of 
leaders in addiction services from the medical, community/voluntary and research fields. 
The Community Detoxification Guidelines have been developed in line with:
• the QuADS Organisational Standards (Ana Liffey Drug Project and Health Service 
Executive, 2014);
• the National Drugs Strategy (interim) 2009-2016 (Department of Community, 
Rural and Gaeltacht Affairs, 2009);
• the Introduction of the Opioid Treatment Protocol (Farrell & Barry, 2010);
• the National Drugs Rehabilitation Framework (Doyle & Ivanovic, 2010);
• the National Protocols and Common Assessment Guidelines: to Accompany 
the National Drugs Rehabilitation Framework (National Drugs Rehabilitation 
Implementation Committee, 2011).
2.1 Community Detoxification Steering Committee
The following were responsible for the development of the guidelines:
Dr Ide Delargy (ICGP)
Dr Austin O’Carroll (Safetynet)
Dr Des Crowley (HSE)
Dr Joanne Fenton (Access team)
Dr Suzi Lyons (HRB)
Ruaidhri McAuliffe (UISCE)
Tony Duffin (Ana Liffey Drug Project)
Brian Friel (Peter McVerry Trust)
2.2 Professional liability
The Community Detoxification Guidelines are a set of guidelines to assist professionals 
to support service users through a community-based detoxification. It is the 
responsibility of the organisations involved to ensure that staff providing Community 
Detoxification are competent in their role and trained in relapse prevention and 
care planning. Additional insurance is not required for the provision of Community 
Detoxification. This work should be included in the service’s current insurance policies.
9The Community Detoxification Steering Committee and the organisations associated 
with the development and production of the Community Detoxification Guidelines do not 
accept responsibility for any harm to service users undergoing Community Detoxification 
while working in line with these guidelines.
2.3 Uses and limitations of these guidelines
Community Detoxification is a structured detoxification process in a non-residential 
setting. These guidelines do not make recommendations for crisis detoxification, 
residential treatment or detoxification within a prison setting. Furthermore, these 
guidelines do not make recommendations for the detoxification of non-listed substances 
such as alcohol or the detoxification of pregnant women. Community Detoxification 
should be readily available to service users seeking treatment. To ensure service users’s 
safety, there are medical contraindications which may exclude certain service users 
from accessing Community Detoxification. An individual’s suitability to participate in 
Community Detoxification is determined on an individual basis by the GP involved.
2.3.1 A step towards residential detoxification
Community Detoxification can be used to assist service users reducing or stopping 
their use of methadone, benzodiazepines or Z hypnotics in order to meet the entry 
requirements of residential treatment facilities.
2.4 Community-based services
The Introduction of the Opioid Treatment Protocol (Farrell & Barry, 2010) recommends 
that all service users should be offered detoxification as a treatment option and 
acknowledges that there is a role for community-based services in providing potential 
key working supports in relation to all treatment options. Further recommendations 
state that the establishment of stronger links between general practice, pharmacy and 
community drug projects are desirable.
2.4.1 History and rationale for the Community Detoxification Protocols
The Community Detoxification Protocols were developed in the North Inner City Drugs 
Task Force Area in Dublin, in response to a gap in treatment options for service users 
wishing to reduce or cease their methadone or benzodiazepine use. This issue was 
identified in ‘We’re People Too’ (O’Reilly, Reaper & Redmond, 2005) and through anecdotal 
evidence from service users who reported that Community Detoxifiction options were 
not available to them. In these instances, service users reported feeling disempowered 
from their treatment and frustrated that they had limited pathways to address their 
issues or attain their goals. Through initial consultations, doctors prescribing methadone 
raised concerns that service users who engaged in a community-based detoxification 
without adequate preparation or support were at considerable risk of overdose and fatal 
overdose. GPs also highlighted that they had limited consultation times and were not in a 
position to provide the necessary psychosocial supports required for safer detoxification 
in the community.
In 2007, the Ana Liffey Drug Project and Community Detoxification Steering Committee 
responded to this issue. The concerns of service users, doctors and drug services guided 
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the formation of an initial interagency steering group to progress the idea of formalised 
Community Detoxification Protocols. The protocols aimed to outline a clear process for 
how service users would be assessed as appropriate for a Community Detoxification and 
how GPs and key workers could coordinate to provide effective supports while managing 
the risk of relapse and overdose. Following an 18 month implementation period, the pilot 
was evaluated under the direction of the Steering Croup.
2.4.2 North Inner City Drugs Task Force Community Detoxification 
Evaluation
The protocols and pilot scheme were launched in April 2007, and evaluated in early 
2009. The evaluation, which included service users, key workers and GPs, revealed a 
predominantly positive experience of the pilot scheme. 
The main findings were:
• 16 out of 29 service users had an initial introductory meeting.
• Out of these 16, 7 had successfully completed the Community Detoxification and 
7 were still engaged. Only 2 disengaged once a GP had become involved in the 
process.
• 4 of the 29 service users disengaged at the key working phase.
• 4 of the 29 service users received another service such as maintenance or 
aftercare.
• Referrals were spilt between: self-referral (48%); community/voluntary (31%); 
and medical services (17%).
• Detox requests were similarly spilt between opiates related (55%, n=16) and 
benzodiazepine related (45%, n=13).
• Service users reported a positive experience overall; all of them said they would 
recommend the process to a friend.
2.5 National Pilot
In response to a number of referrals from outside Dublin’s North Inner City and growing 
interest in the initiative, a national pilot scheme was proposed to, and approved by, the 
Steering Committee. A number of geographical areas were prioritised for inclusion in 
the National Pilot Scheme in autumn 2011. 
2.5.1 Updated guidelines
Building on the experience of the pilot scheme, the Community Detoxification Protocols 
(Ana Liffey Drug Project, 2011) were reviewed by the Ana Liffey Drug Project in 2015. 
The current guidelines were developed from the Community Detoxification Protocols 
and provide updated information on Community Detoxification. The new guidelines are 
now available to services nationally. By building on experience, these guidelines aim to 
improve service delivery and ensure the best possible practice.
2.5.2 Changes in these guidelines
The current guidelines provide updated information including:
• guidance for detoxification of Z hypnotics;
11
• removal of mandatory broker role in the Community Detoxification structure;
• different stages in the detoxification process;
• an initial assessment by the GP to ensure service user suitability;
• acknowledgement of dual diagnosis and mental health symptoms as a factor in 
the Community Detoxification process;
• provide online information for GPs and key workers.
The changes to the protocols have been made to enhance service delivery, and to 
emphasise the centrality of the relationship between the service user, key worker and 
doctor. However, this is not to say that additional supports cannot be implemented. The 
Steering Committee fully recognises, and wishes to emphasise, the importance of local 
knowledge and expertise in ensuring successful delivery of services. There is nothing to 
prevent services mandating an individual or agency locally to promote and / or coordinate 
the new guidelines.
2.5.3 The Ana Liffey Drug Project
The vision of the Ana Liffey Drug Project is for a society where all people affected 
by problem substance use are treated with dignity and respect and have access to 
quality services. The organisation’s mission is to work with people affected by problem 
substance use and the organisations that assist them. It’s aim is to reduce harm to 
service users and society, and to provide opportunities for development of those service 
users and organisations. Working in partnership, the Ana Liffey Drug Project aims to 
improve the range of accessible services available to people who use drugs.
2.6 Guideline structure
These guidelines are structured to make Community Detoxification a clear process 
for professionals. This document is divided into separate chapters with relevant topics 
included in each. 
Chapter 1 and chapter 2 give an introduction and summary of service delivery.
This section provides an overall description of the service. 
Chapter 3 and 4 present the psychosocial and medical support roles in line with the 
guidelines. These chapters are relevant to those who are currently, or who intend to, 
provide support in the area of Community Detoxification. 
Chapter 5 provides clinical recommendations for both psychosocial and medical 
supports. 
Chapter 6 includes relevant information relating to substances and Community 
Detoxification.
2.7 Summary 
These guidelines outline the agreed minimum standards for the delivery of Community 
Detoxification support. The aforementioned standards of care are delivered through 
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psychosocial and medical supports.
The minimum standards are:
• Care Planning: Care planning takes into account all factors that may negatively 
impact on an individual’s capacity to engage in a successful Community 
Detoxification such as housing or family matters, as well as those which may 
promote success, such as meaningful use of time and social supports.
• Relapse prevention: Structured sessions aim to provide service users with a skills 
and knowledge base around drug use, harm reduction, risk and relapse.
• Medical support: Regular medical appointments are provided to supervise the 
detoxification. The prescribing GP agrees to engage in communications with the 
Key Worker, regarding the service user’s progress, and in particular, any change to 
the initial detoxification schedule or care plan.
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3. Delivering Community 
Detoxification
This section outlines the key components required to deliver Community Detoxification.
Community Detoxification should include: 
• A named key worker or health care professional who will provide psychosocial 
support.
• A prescribing GP who delivers a physical and mental health assessment, medical 
support and detoxification.
 
 
3.1 Psychosocial support
It is the responsibility of the organisations involved to ensure that staff providing 
Community Detoxification are competent in their role and have the appropriate level 
of training to cover their work. Key workers are required to be trained in key working, 
relapse prevention and care planning. 
The recommended time which should be allocated by the key worker to support the 
service user is two hours per week for the first month and one hour per week thereafter. 
It is acknowledged that some cases may require additional support. 
3.2 Medical support
The GP involved with a Community Detoxification will monitor the medical aspects 
related to detoxification. The GP will work within the scope of the Community 
Detoxification Guidelines. Their competencies are integral to their professional medical 
qualification and do not require additional validation through this process. The GP 
is responsible for establishing who is suitable for Community Detoxification and will 
provide medical reasons for those deemed unsuitable. 
3.3 Professional relationships
These guidelines place emphasis on psychosocial and medical support as part of 
Community Detoxification. It is recommended that the key worker, prescribing GP and 
service user develop a reliable relationship from the initiation of the process.
The key worker should communicate proactively with the GP and be informed about 
the individual’s suitability, suggested care plans, detox schedules and changes in 
arrangements. The key worker should communicate details of the service user’s 
care plan and any major adjustments to the care plan to the prescribing GP, while 
also keeping the GP updated on any issues which arise during the process. Both the 
prescribing GP and key worker are expected to be mindful of the mental health of the 
service user throughout the process and to discuss any issues if they arise.
It is recommended that the key worker accompanies the service user for the initial 
assessment with the GP and presents the GP with a drug diary and the Key Work 
Assessment Form (Appendix 3). The purpose of this is for all parties involved to discuss 
individual suitability, more specifically, what is expected of the service user and what 
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options are available to them. If this is not possible, the key worker is required to call 
the GP (in the presence of the service user) to arrange the health assessment with the 
GP, followed by sending the GP by email the service user’s drug diaries and assessment 
forms, which are to be reviewed as part of the process. With the service user present, the 
key worker is required to call the GP to discuss the GP assessment outcomes.
 
3.4 Under 18s
Service users under the age of 18 are required to attend a Tier 3 service if they wish to 
participate in Community Detoxification. As the detoxification of adolescents can be more 
complex than that of adults, the appropriate treatment setting for detoxification needs 
to include a range of medical, psychological and social supports. Tier 3 services have 
specialist expertise in both adolescent mental health and addiction. 
A Tier 3 service must have a multi-disciplinary team with expertise in the following:
• Medical treatment options for addiction disorders (child psychiatrist, psychiatrist 
registrar or GP).
• Treating comorbid disorders.
• Child protection issues (social worker).
• Outreach (an experienced outreach worker).
• Assessment of developmental issues (child psychiatrist or clinical psychologist).
• Delivering individual or group psychotherapeutic interventions.
• Systemic or family therapy.
It is advised that complex cases are directed towards inpatient treatment facilities.
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4. Community Detoxification Steps
The Community Detoxification process can be divided into the following six phases:
1. The establishment of a key work relationship.
2. Key work preparation for GP health assessment.
3. Health assessment by the prescribing GP.
4. Key work preparation for detoxification.
5. Detoxification.
6. Aftercare / progression to residential treatment.
In order to begin the Community Detoxification process, an individual must have 
an appropriately trained key worker who is willing to work within the Community 
Detoxification Guidelines. 
4.1 Establishing a key work relationship
Each service user intending to engage in Community Detoxification will require a key 
worker to prepare them for the process. 
If the service user currently has an appropriately trained key worker, he or she can 
receive Community Detoxification psychosocial support from that individual. 
Psychosocial support can be provided by any appropriately trained health professional 
who can provide assistance with relapse prevention and care planning.
4.2 Key work preparation for GP assessment 
The key worker must work with the service user to prepare him / her for the initial 
meeting with the GP. Preparation for this meeting involves the key worker completing the 
forms listed in Appendices1, 2 and 3. The GP health assessment is a physical and mental 
assessment completed by the prescribing GP to ensure service user suitability.
• When a service user requests a Community Detoxification, it is the role of the key 
worker to complete the initial forms provided in these guidelines.
• It is necessary for the service user to be informed of the Community Detoxification 
process and to be made aware that the overall decision of detoxification suitability 
is decided by the prescribing GP on completion of an assessment.
• Risk management and harm reduction techniques must be explained to, and 
understood, by the service user. The service user is required to be fully aware of 
positives and negative aspects of participating in Community Detoxification.
• Once the key worker has completed the required documents with the service 
user, the prescribing GP can be contacted to schedule an assessment.
• It is essential that the Key Work Assessment Form (Appendix 3) and drug diary 
are prepared and presented to the prescribing GP as part of the assessment. 
These forms assist the GP in the process. 
• It is recommended that the key worker accompanies the the service user to the 
GP assessment. If the key worker cannot attend, the Key Work Assessment Form 
and drug diary should be sent to the GP by email.
• On condition that the GP considers the service user is suitable for Community 
Detoxification, the key worker can then begin preparation for detoxification.
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• In the event of the service user not being suitable for Community Detoxification, 
it is the role of the key worker to assist this individual in finding a different 
treatment option.
4.3 GP assessment
A GP assessment is required as part of these guidelines to establish the extent of the 
service users substance use and to examine his / her physical and mental health. This 
assessment is completed by a prescribing GP who is prepared to work as part of the 
Community Detoxification Guidelines. The GP provides the medical support involved in 
detoxification and determines service user suitability to ensure patient safety.
Assessment recommendations:
• It is the role of the prescribing GP to ensure that the service user is suitable for 
detoxification in a community setting.
• The physical and mental health of the service user needs to be considered before 
preparation work commences.
• If the service user has mental health concerns, it is at the discretion of the GP to 
proceed to detoxification.
• If the service user is currently attending a professional for mental health 
reasons, this individual must be included in the decision-making process with the 
prescribing GP.
• For the purpose of the assessment, the prescribing GP will be provided with the 
Key Worker Assessment Form (Appendix 3) and drug diary.
4.4 Medical contraindications to Community Detoxification
Medical contraindications need to be reviewed as part of the service user’s suitability 
to engage in the Community Detoxification process. If a service user is contraindicated 
as per the criteria below, that person is not automatically excluded from engaging in 
a Community Detoxification. However, service user suitability for detoxification is the 
decision of the prescribing GP. 
Factors which may mean a service user is not suitable for Community Detoxification are:
• psychosis or severe mental health problems which are currently untreated;
• a history of epileptic seizures while undergoing detoxification;
• major medical illness;
• possible dual addiction, where both addictions are unstable or where a second 
addiction other than opiates is uncontrolled, for example cocaine, alcohol and 
benzodiazepines;
• pregnancy.
4.4.1 Community Detoxification and pregnancy
The Community Detoxification Guidelines do not recommend the use of these guidelines 
for community-based detoxification for pregnant women. This is due to the complexity 
of the withdrawal and the possible risks to the mother and foetus. It is recommended by 
the Institute of Obstetricians and Gynaecologists and Health Service Executive (2013) that 
all pregnant women receive services from specialised or high risk antenatal clinics. If a 
service user involved in Community Detoxification becomes pregnant, the GP should be 
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notified to examine the service user in order to advise on the best available services, and 
to connect with the Drug Liaison Midwife linked to the relevant maternity hospital. 
4.4.2 Other factors
Other factors to be considered are:
• The service user’s living situation.
• Current relationships.
• Cannabis and alcohol use.
• Unexpected life events.
• Failed attempts at Community Detoxification in the past.
Note: Service users should be assessed on an individual basis with consideration to their 
personal situation.
The contrandications relative to Community Detoxification are established on an 
individual basis. Service users with dual addiction, mental health concerns and poly drug 
use can access Community Detoxification in certain situations.
4.5  Dual addiction
Service users could present for detoxification with an addiction to more than one 
substance. Dual addiction can be a medical contraindication for detoxification because of 
the risks associated with poly drug use, such as overdose and death.
When can a service user with dual addiction access Community Detoxification?
The issue of dual addiction as a contraindication to detoxification needs to be established 
on a case-by-case basis. Dual addiction should be discussed between the prescribing GP 
and the key worker. In some circumstances, it is possible for the prescribing GP and key 
worker to arrange a care plan to manage dual addiction before detoxification is agreed.
Factors when considering dual addiction as a medical contraindication:
• There is a possibility that the individual is addicted to one or more substance 
which could pose a danger during detoxification. The risk of overdose is greatly 
increased when certain drugs are used in combination.
• Dual addiction, which includes an addiction to cannabis, could represent a 
contraindication depending on the amount consumed and the effect this has on 
the service user individually. 
Benzodiazepines and methadone
If the service user is using both benzodiazepines and methadone he / she could be 
suitable for Community Detoxification. In this situation, benzodiazepines should be 
detoxed first followed by methadone. 
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Alcohol and other substances
Alcohol use in conjunction with other substances can pose a serious risk of fatal 
overdose to the service user. There is a higher risk of overdose or fatal overdose 
during or after detoxification. It is advised that problem drinking should be managed 
through a care plan prior to engaging in the Community Detoxification process. Alcohol 
use can lead to impaired judgment and increase the risk of relapse to unprescribed 
benzodiazepine use leading to overdose and death. Prescribing benzodiazepines to 
someone who is using alcohol increases that individual’s risk of overdose and death. 
However, decisions on this issue are at the GPs discretion and should be made between 
the service user and the prescriber. Service users should be fully informed of the 
heightened risks and consequences of combined benzodiazepine, reduction and alcohol 
use.
Alcohol use can be managed through complete alcohol detoxification, reduction in use, 
or other harm reduction or risk management strategies. As with any situation where 
there is a heightened risk to the service user, additional medical and psychosocial 
supports should be provided. Based on the severity of the service users alcohol use, 
the GP or key worker may advise that the service user attend residential treatment to 
complete an alcohol detoxification programme before being considered suitable for 
Community Detoxification.
If the service user is already engaged in the detoxification process and concerns arise in 
relation to the service user’s alcohol consumption, the key worker is obliged to inform 
the GP as soon as possible. This should be managed as with any increased risk during 
the detoxification process: through additional supports, structured care planning and 
ongoing interagency communication.
Psychosocial support
The decision regarding whether psychosocial support can assist the individual in 
overcoming dual addiction should be determined on an individual basis. 
Factors which need consideration are:
• The substance involved.
• The length of time the substances are being used.
• The number of substances being consumed.
• Motivation.
• Living situation.
• The dangers which might be associated with dual addiction.
It may be decided that psychosocial support should be directed towards the reduction 
of other substances before the GP considers the service user is suitable for Community 
Detoxification. If dual addiction cannot be managed in a community setting the individual 
should be directed towards an appropriate treatment option.
When is dual addiction a barrier to community detoxifaction?
• If the prescribing GP / key worker consider it is a risk for the service user.
• If the prescribing GP / key worker consider the severity of dual addiction cannot 
be overcome by psychosocial support in the community.
• If psychosocial support in the community has been provided and it has not helped 
the service user overcome the dual addiction.
21
4.5.1 Poly drug use
Poly drug use is the use of more than one drug or type of drug by an individual — 
consumed at the same time or sequentially. 
When can a service user who is a poly drug user access Community Detoxification?
The risk of overdose is greatly increased when certain drugs are used in combination, 
particularly opiates (codeine, heroin, and methadone), benzodiazepines, tranquillizers, 
sleeping tablets, anti-depressants and alcohol. The use of cannabis may not be 
considered as harmful, but could pose as a contraindication depending on the amount 
consumed and the effect this has on the service user individually. Poly drug use can be 
reduced through psychosocial support provided by the key worker before detoxification is 
recommended.
When is poly drug use a barrier to community detoxifaction?
Poly drug use can be a medical contraindication depending on the substances used 
and the risks which these pose to the service user. Psychosocial support should aim 
at addressing poly drug use with the service user as part of that individual’s care plan 
leading towards detoxification. 
4.5.2 Mental health
When should mental health issues not exclude a service user?
A mental health assessment is an essential stage of Community Detoxification. Dual 
diagnosis is common among the drug-using population. Studies have shown that 
the occurrence of comorbid mental disorders in service users who use psychoactive 
substances can be high (European Monitoring Centre for Drugs and Drug Addiction, 
2013). 
Drug use may cause one or more symptoms of mental health disorders. Symptoms can 
result directly from drug use or indirectly from the lifestyle and conditions the drug user 
experiences. Dual diagnosis can also be present with those who have existing mental 
health disorders and use substances to self-medicate. The area of dual diagnosis can be 
complicated as symptoms can overlap. The conditions may present at the same time or 
at different stages of an individual’s life. 
These guidelines acknowledge that service users might present for assessment while 
displaying symptoms of mental health disorders. Service users may experience anxiety 
disorders, depressive disorders, extreme stress, drug-induced delusions and aggression. 
These guidelines attempt to provide the best possible guidance in this area for a 
Community Detoxification.
Community Detoxification requires:
• A Key Work Assessment Form (Appendix 3). This form collects information 
relating to symptoms and is presented to the GP in order for an assessment to be 
conducted.
• A GP assessment to ensure patient suitability.
• Observations by the key worker and GP of the service user’s mental health status 
throughout preparation, detoxification and aftercare and communication of any 
possible risks regarding the service user’s health. 
• Acknowledgment that mental health concerns may be present and consideration 
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of the best options for the service user. Mental health treatment could be 
introduced as part of the care plans for certain service users.
• Inclusion of mental health professionals if they are working with the service 
user. The mental health professional should be involved in the decision-making 
process with the GP.
The most appropriate treatment setting for the service user will be determined by the 
outcomes of the GP assessment, combined with the professional judgement of the GP 
and key worker. A service user may need to access mental health treatment before 
meeting the Community Detoxification requirements. By completing a mental health 
assessment, service users can be linked in with other services, if appropriate. 
Important considerations regarding service users with dual diagnosis:
• The level of risk involved for the service user in the community.
• The service user’s capacity to take prescribed medication.
• If services are available, a multidisciplinary team can be involved in the process.
What mental health symptoms should be contraindications?
During the initial Community Detoxification key work session, the Key Work Assessment 
Form should be completed and presented to the GP in order for an assessment to be 
conducted. This form records information relating to symptoms of severe mental illness.
The GP can use the standard method of assessing mental health issues and also review 
the Key Worker Assessment Form. During this assessment the GP shall examine the 
service user for currently untreated severe mental health issues and psychosis. It is 
recommended that current and untreated severe mental illness and psychosis should 
exclude a service user from Community Detoxification.
Signs and symptoms of severe mental health issues and psychosis may include:
• Detachment from reality
• Hallucinations
• Delusions
• Confused and disturbed thoughts
• A lack of insight and self-awareness
• Hearing voices
• Paranoia
• Intent to hurt oneself or others
4.6 The choice of setting 
How should the appropriate treatment setting for the service user be decided?
It is the role of the GP to decide if Community Detoxification is suitable for a service user.
The GP might consider a service user is unsuitable if they are: 
• medically contraindicated;
• experiencing mental health issues which need to be resolved before 
detoxification;
• currently in an unsuitable environment;
• experiencing difficulties which need addressing before commencing.
In the event of a service user not being suitable for Community Detoxification it is the 
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role of the key worker to establish an appropriate treatment setting through assessment 
and care planning in line with the National Drugs Rehabilitation Framework.
The key worker will need to assess the service user’s current situation regarding:
• current drug use;
• childcare commitments;
• work and education commitments;
• current living situation;
• expectations from treatment;
• previous treatment and history of withdrawals.
In line with Protocol 3 (Referral between agencies) of the National Drug Rehabilitation 
Framework, the key worker will need to research treatment facilities and examine:
• requirements for treatment facilities;
• the programmes delivered by the treatment facilities;
• the length of time of the treatment;
• the location of the treatment facility;
• waiting lists;
• any specific supports required for mental health and childcare needs.
It is acknowledged that there may be requirements and waiting lists for residential treatment. 
The key worker should continue the care plan and support until the service user is accepted 
to the appropriate facility.
24
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5. Psychosocial support
It is the responsibility of the organisations involved to ensure that staff providing 
Community Detoxification are competent in their role and have the appropriate level 
of training to undertake their work. The key worker will need to be trained in relapse 
prevention and care planning. 
As part of the Community Detoxification Guidelines, psychosocial support is a core 
component in its delivery to service users. It is necessary that the service user attend key 
work sessions weekly.
It is recommended that key work sessions of a minimum of two hours per week occur for 
the first month and one hour per week thereafter. If the service user is failing to attend 
key work sessions, this issue needs to be brought to the attention of the prescribing 
doctor.
The role of the key worker is to:
• Adhere to the Community Detoxification Guidelines.
• Ensure the service user is aware of the detoxification process.
• Carry out assessments to identify and prioritise needs for that individual.
• Complete the Key Worker Assessment Form (Appendix 3) and one drug diary to 
present to the GP for the GP assessment.
• Create, discuss and implement a treatment plan with the service user before, 
during and after detoxification.
• Regularly review the established care plan.
• Consider risks such as overdose, self-harm and withdrawal symptoms.
• Assess and act upon immediate risk of danger to substance use
• Highlight the risks and positive aspects of detoxification to the service user 
throughout the detoxification process.
• Inform the service user of risk management techniques.
• Establish cues and triggers of drug use with the individual.
• Develop strategies with the service user to reduce the risk of relapse.
• Proactively communicate with the GP involved in the detoxification process.
• Contact the GP if a service user is not attending key working sessions.
• Communicate to the GP if the service user is having difficulty with the chosen 
detoxification schedule.
• Inform the GP of any mental health issues or major life events which have 
occurred for the individual during detoxification.
• Be mindful of changes in the service user’s mental health.
• Ensure that service users have access to a wide range of services.
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6. Key work process
6.1 Preparing for the GP assessment
Overview 
When Community Detoxification has been identified as a goal within the service user’s 
care plan, the key worker should meet with the service user to discuss the Community 
Detoxification process, to complete the necessary forms and to arrange an appointment 
with the GP for an assessment.
Process
1. The preparation for the GP assessment is an important process where the 
key worker ensures that the service user is fully informed of the Community 
Detoxification Guidelines and any other treatment options available.
2. It is the role of the key worker to complete the initial Community Detoxification 
forms (Appendix 1, 2 and 3) with the service user and to clarify any areas of 
uncertainty.
3. At this stage it is essential for the key worker to arrange for a GP to provide an 
assessment. 
4. If the service user’s GP wishes to provide the detoxification, it is the role of the key 
worker to make the GP aware of the Community Detoxification Guidelines.
5. It is the role of the key worker to find a GP who will provide a detoxification as 
outlined within the Community Detoxification Guidelines, if the service user’s 
current GP cannot provide the detoxification. 
6. The key worker must complete the Key Worker Assessment Form (Appendix 3) 
to present to the GP with one drug diary. If the key worker is unable to attend 
the GP appointment, the forms must be sent by email to the GP. For patient 
confidentiality reasons, it is recommended that these documents not be sent by 
fax to the GP’s surgery.
Tools:
 9 Initial check list, participation agreement (Appendix 1&2)
 9 Drug diary
 9 Key Work Assessment Form (Appendix 3)
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6.2 Preparing for detoxification
Overview 
Preparation for detoxification can require a long period of psychosocial support 
depending on the individual and the substances being used. It is during this period that 
the service user must reduce substance consumption and focus on improving skills and 
techniques for addressing the drug use. These guidelines recommend a minimum of 
four sessions over a two-week period for the preparation stage. For some service users 
a longer period than the recommended timeframe might be required. The key worker 
should meet with the service user a minimum of once a week for preparation until the 
latter is prepared for detoxification.
Process
1. A care plan addressing all areas of the service user’s life needs to be completed 
with the individual. Priority must be given to areas of greatest need before 
detoxification. This could be housing or mental health concerns, or other issues. 
2. Relapse prevention techniques must be completed with the service user.
3. The key worker and service user will spend a minimum of two hours per week 
for the first month and a one hour per week there after focusing on relapse 
prevention and care planning. Where a need is identified, these sessions can be 
conducted twice weekly for the initial few months. The tasks of care planning and 
relapse prevention should be clearly differentiated, with time being allocated for 
each.
4. The risk of withdrawal, seizures and overdose during detoxification should be 
discussed with the service user by the key worker to prepare the individual for 
detoxification.
5. If the service user is consuming benzodiazepines they may experience poor 
memory and concentration. In this case, vital work may need to be redone 
between the key worker and the service user. This may prolong preparation for 
detoxification.
6. If the service user does not cease poly drug use and is using significant quantities 
of substances, it is the role of the key worker to address this and discuss the 
individual’s suitability for Community Detoxification with the GP.
7. Additional key work may need to be provided to service users reducing their levels 
of street drugs. This may take a longer period of time and require extra resources.
8. The TOP form (Appendix 4) is provided in this document to help key workers 
examine drug consumption.
9. Drug diaries need to be completed throughout the detoxification process. 
For benzodiazepine detoxes fourteen consecutive days drug diaries must be 
presented to the doctor to initiate the beginning of detoxification.
10. When the key worker feels the service user is prepared and meets the entry 
requirements for detoxification the GP will be contacted.
11. For benzodiazepine detoxifications, the drug diaries and care plan should be 
forwarded to the GP. 
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Tools: 
 9 Drug Diaries
 9 Care Plans
 9 Relapse Prevention Tools – Worksheets, Role-Play 
 9 TOP (Treatment Outcomes Profile) form
6.3 Psychosocial support
Overview
The key worker must support the service user throughout the detoxification process. 
Process
1. During detoxification the service user should continue weekly meetings with the 
key worker.
2. The GP and key worker should communicate with each other if any issues 
(including relapse) arise during the detoxification period.
3. It is essential that the key worker and service user have copies of the 
detoxification schedule compiled with the GP. A care plan should be created 
based on this schedule.
4. Throughout detoxification, awareness relating to risk management and relapse 
prevention should be reinforced.
5. The key worker should continue to complete the TOP form with the service user 
throughout detoxification.
6. Non-medical management of withdrawal symptoms should be explained to the 
service user.
7. A detoxification process may need to be paused if the service user is misusing 
substances or not attending arranged appointments with the key worker or GP.
6.4 Psychosocial support during aftercare
Overview
The key worker and service user should continue to engage in weekly care planning 
and relapse prevention support sessions for six months following completion of the 
detoxification process.
Process
1. Aftercare is an important part of the detoxification process due to risks in relation 
to withdrawal seizures, relapse, and overdose. This can be due to reduced 
tolerance in the period after someone becomes drug-free. 
2. Some service users may choose to enter residential rehabilitation services at this 
point. 
3. Where the service user remains in the community, the key worker will continue to 
provide key working and care planning supports appropriate to the needs of the 
service user. 
4. Where a barrier exists to continuous provision of these supports, or the service 
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user wishes to disengage from the key work service, an alternative provision 
should be made with another appropriate support service where relapse 
prevention and care planning can be provided.
5. In the event of service user relapse, the key worker should make a referral to 
medical support. 
Tools
 9 Care Plans
 9 Relapse prevention techniques
 9 Harm reduction techniques
 9 Information on other appropriate services
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7. Medical support
The prescribing GPs involved with Community Detoxification will monitor the medical 
aspects relating to the detoxification. GP’s competencies are integral to their 
professional medical qualification and do not require additional validation through this 
process. The GP will work within the scope of the Community Detoxification Guidelines 
regarding detoxification schedules. The GP is responsible for establishing who is suitable 
for Community Detoxification and shall provide medical reasons to those whom they 
deem unsuitable. 
The GP should be able to undertake the following:
• Adhere to the Community Detoxification Guidelines.
• Examine the Key Worker Assessment Form and drug diaries.
• Complete an assessment to confirm service user suitability to participate in 
Community Detoxification.
• Create a detoxification schedule agreement with the service user.
• Discuss dose and reduction with the service user in a collaborative and flexible 
manner.
• Monitor medication concordance.
• Monitor the service user’s physical and mental health status throughout 
detoxification.
• Communicate regularly with the key worker.
• Reassess detoxification if mental or physical health concerns arise.
• Reassess detoxification if the service user is neglecting to attend appointments.
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8. Medical support process
8.1 GP assessment
Overview
Community Detoxification provides medical supervision by a GP within the community. To 
assess the service user’s suitability, the GP must complete a health assessment. During 
this assessment, the GP determines if the service user is both physically and mentally 
suitable for Community Detoxification
Process
1. The GP is presented with the Key Worker Assessment Form (Appendix 3) and a 
completed drug diary.
2. The GP examines a history of the service user’s drug use and medical / treatment 
history.
3. A record must be kept of all medication which the service user is currently 
prescribed.
4. The GP can determine if there are any medical or mental health contraindications 
which might be a risk to the service user.
5. If the GP is unsure of the suitability of the service user, they can consult with the 
key worker.
6. During the assessment the GP will inform the service user what is expected of 
him or her to meet the entry requirements for detoxification. A dose reduction 
care plan can be advised to help the individual meet the recommended entry 
criteria. 
7. If the key worker cannot accompany the service user to the GP assessment, the 
key worker should contact the GP to inform the GP of the service user’s suitability 
and what is expected of the service user to be accepted to the detoxification stage.
8. If the GP considers the service user is unsuitable for Community Detoxification, 
the key worker should be provided with specific details of the decision.
9. By informing the key worker of suitability, the GP and key worker can then choose 
an appropriate detoxification setting.
Tools
 9 Key Worker Assessment Form
 9 Record of Medication and Illness
8.2 Detoxification
Overview
At this stage the GP begins prescribing and the service user begins to reduce medication 
in line with a schedule agreed with the GP. The key worker continues to provide care 
planning support and relapse prevention throughout the detoxification period.
Process
1. Following receipt of the drug diaries, and if the GP is agreeable to begin the 
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detoxification, the GP is required to inform the key worker of this decision. The 
GP should make the detoxification schedule available to both the key worker and 
service user.
2. The GP should meet with the service user every two weeks, although 
appointments can be provided more frequently, or less frequently, depending on 
factors relating to the service user’s stability. This is at the discretion of the GP. 
3. Daily dispensing from the pharmacy should be in place. After a given period of 
time this may be reconsidered where the service user is showing commitment to 
detoxification. A move to less frequent dispensing may be used as an incentive to 
continued progress. 
4. If the service user is showing commitment to the detoxification process and has 
extraneous commitments, such as work or family, this can be facilitated by less 
frequent dispensing 
5. The key worker and service user should continue a minimum of once-weekly 
meetings. 
6. Where there is an issue or concern perceived by the key worker, GP, or service 
user, regarding risk of relapse, or capacity to adhere to the detoxification 
schedule, then the service user will be invited to a three way meeting to discuss 
issues arising.
7. Where a service user misses an appointment, the key worker and GP should 
endeavour to make contact with the service user in order to highlight risks. 
8. If the service user misses two appointments with the GP or key worker without 
reason or rescheduling, then this should be discussed between the GP and the 
key worker. 
Tools
 9 Drug Diaries
 9 Detoxification Schedules
 9 Conversion Tables
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9. Disengagement
Disengagement refers to when a service user ceases to engage with the Community 
Detoxification process. 
It is important to note that if a service user cannot meet entry requirements for 
the detoxification, decides not to begin the detoxification, or does not complete the 
detoxification process, this should not be considered as a failure by the service user. 
Efforts should be made by all professionals to highlight the achievements of the 
individual to date and the lessons learned for the future. As with any treatment option, in 
some instances Community Detoxification may not be suitable for a particular person at 
a certain point in time. 
9.1 Definition of disengagement
Where the service user has begun detoxification and the GP has begun prescribing, the 
service user is considered to have disengaged with the process if they: 
• do not attend two or more consecutive meetings with the key worker and have not 
provided reasonable explanation or attempted to make alternative arrangements 
with the key worker (this also applies during aftercare);
• are perceived by the doctor or key worker to be ‘topping up’ on their prescribed 
medication, or otherwise using their prescribed medication inappropriately, and 
are unwilling or unable to address this behaviour when offered support to do so.
9.2 Outcomes of disengagement 
Where a service user has disengaged, the following steps may be taken: 
• The key worker and GP should endeavour to make contact with the service user 
to highlight overdose risk.
• The key worker should attempt to make contact with the service user, and discuss 
the service user’s care plan, adapting it as necessary to suit changing needs or 
circumstances. 
• The GP will encourage the service user to reengage with the latter’s key worker 
and may continue to prescribe until a zero dose is reached in line with the original 
schedule.
• The GP might cease prescription where it is felt that to continue to prescribe 
could pose a greater risk to the health of the service user than to cease 
prescription.
9.3 Re-engagement/requests for a second detoxification
Due to the high risks associated with detoxification, a service user presenting after 
disengagement, or relapse, should be referred back to medical supports as soon as 
possible. Decisions regarding prioritisation, re-entry dose and subsequent detoxification 
are based on assessments made by the prescribing GP. These will vary from case to 
case. Factors such as whether the service user is (or was in receipt of) a prescription for 
benzodiazepines, will be taken into account.
Re-engagement may be facilitated once commitment to the process and appropriate 
preparation has been evidenced as per the entry criteria to a Community Detoxification 
in accordance with the Community Detoxification Guidelines. Additional requirements, 
or a prolonged period of preparation, may be identified as necessary by the service user, 
GP or key worker. The care plan should clearly address any issues that precipitated the 
service user’s previous disengagement. 
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10. Benzodiazepines
10.1 Definition
Benzodiazepines are defined as a large family of drugs used as hypnotics, anxiolytics, 
tranquillizers, anticonvulsants, pre-medication, and for intravenous sedation. They differ 
in their duration of action, metabolites and lipid solubility. They are commonly prescribed 
in the treatment of anxiety and insomnia. Guidelines recommend they be prescribed for a 
maximum of 2-4 weeks as benzodiazepines are recognised as being highly addictive.
10.2 Benzodiazepine detoxification
This section outlines steps in the Community Detoxification process: assessing 
suitability; meeting entry requirements; and the detoxification process itself. It is 
important to note that where the guidelines are being used it is presumed that all parties 
are working in line with these guidelines.
10.3 Before benzodiazepine detoxification
The following should be considered before commencing detoxification:
• The service user needs to have shown motivation towards some control of 
his / her benzodiazepine use and wants to reduce and his / her use of other 
substances.
• Service users could be misusing opioids and benzodiazepines. If the service user 
requests a Community Detoxification for both opioids and benzodiazepines, the 
individual must be stable on a prescribed amount of methadone and complete the 
benzodiazepine detoxification first.
• Preparation for detoxification can extend over a long period of time depending on 
the individual.
• Benzodiazepine detoxes are more complicated than opioid detoxes - due to the 
side effects and multiple withdrawal symptoms - therefore more psychosocial 
support may be required.
• Benzodiazepine detoxification can cause multiple withdrawal symptoms such as 
restlessness, anxiety and insomnia.
• Service users may experience impaired memory and concentration, therefore 
professionals could be required to repeat information and work which has been 
previously completed.
• Benzodiazepines cause emotional blunting for individuals. During detoxification 
the emotions which have been repressed could re-emerge.
• Long term benzodiazepine use can cause depression. This is usually resolved 
between six months to a year after use stops.
• Benzodiazepine use can exacerbate existing depression and cause suicidal 
tendencies in those experiencing depression.
• Service users may be consuming a large amount of street benzodiazepines. Key 
work might need to support the service user in reducing their street dose before 
detoxification can begin.
• Depending on the individual, preparation for benzodiazepine detox may require a 
long period of time.
• Psychosocial support may be required to resolve poly drug use before detox 
preparation can begin.
• The service user is required to complete his / her detoxification to a zero dose.
• The consumption of alcohol and other substances during a benzodiazepine 
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detoxification can cause a fatal overdose.
• Six months aftercare must be agreed to with the key worker or another service 
post detoxification.
10.4 Entry Requirements
Entry requirements aim to ensure, as much as possible, that a service user is adequately 
prepared, supported and motivated for detoxification. Urinalysis will provide information 
on opiate use, but in the case of benzodiazepines and Z hypnotics, current use cannot 
be measured easily. In each instance, the professional opinion of the key worker and GP, 
based on their assessment of the service user, will play a considerable role in assessing 
whether or not the service user meets the entry criteria and is ready to undergo 
detoxification.
The following requirements should be met prior to detoxification:
• Provide a minimum fourteen consecutive days’ drug diaries for the period 
immediately leading up to initiation of detoxification.
• Attendance at a minimum of four sessions covering relapse prevention and care 
planning and completion of an interagency care plan. While these sessions can 
take place over a minimum of two weeks leading up to the detoxification process, 
ongoing weekly sessions should take place until the service user is ready and 
meets all entry requirements.
• Ability to participate in key work and engage in appointments. It is acknowledged 
that service users may present affected. Key work and appointments should only 
be cancelled if the service user is unable to participate. 
• The service user must be consuming 40mg or less of benzodiazepines to begin 
a Community Detoxification programme within the recommendations of the 
guidelines.
10.5 Risks during and after benzodiazepine detoxification
1. Benzodiazepine/ benzodiazepine-like drug detoxification increases the risk of 
overdose and seizures
Benzodiazepine detoxification increases the risk of overdose and fatal overdose. During 
and after detoxification, an individual’s tolerance diminishes. If a relapse occurs, the 
service user is at a much higher risk of overdose than during use. Where benzodiazepine 
use is stopped suddenly, there is an increased risk of seizures occurring. The safest way 
to undertake the benzodiazepine detoxification process is by means of gradual dose 
reduction under medical supervision.
2. Poly drug use increases the risk of overdose
The use of any drug carries a risk of overdose. This risk is greatly increased when 
certain drugs are used in combination, particularly opiates (codeine, heroin, methadone), 
benzodiazepine, tranquillizers, sleeping tablets, anti-depressants and alcohol.
3. Injecting benzodiazepines is dangerous
Benzodiazepine tablets can be crushed and injected. This can lead to an increased risk 
of vein damage, infection and overdose.
4. Sharing injecting or snorting equipment increases the risk of acquiring HIV and 
other blood-born viruses
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When the service user undergoes detoxification, that person may no longer carry his or 
her own works or other equipment. If the user relapses there may be a higher risk of 
having to share equipment than when using regularly.
10.6 Areas to plan for during and after detoxification
1. Cravings
Craving for drugs can continue for a while or can occur unexpectedly. Through relapse 
prevention, it is the role of the key worker to help the service user plan to deal with 
expected and unexpected cravings.
2. Stress
Often people who have used drugs for a number of years respond to stressful situations 
by taking drugs.
3. Confidence after completion 
When the service user finishes the detoxification process, there remains a serious risk 
of relapse. Often this can be the most difficult time for people. Developing and following 
an aftercare plan with the key worker, which includes care plan supports and relapse 
prevention, can help the service user move on safely and manage risk after finishing the 
detoxification.
4. Relationships
While most people around the service user will hopefully be a source of support, some 
people in their immediate circle may not. As part of the care plan, the key worker is 
required to help the service user to plan how to deal with these issues.
5. Loneliness 
Major lifestyle changes can mean that people feel isolated or lonely. An important 
part of care planning can be for the service user to work with the key worker and find 
meaningful ways to fill the spaces in the day and establish new social networks.
10.7 Exit points
Exit points will differ between guidelines. Methadone detoxification may be paused 
or suspended and a maintenance dose prescribed, whereas the aim under the 
benzodiazepine and Z hypnotic guidelines are to reduce to a zero dose. There may 
be situations where prescribers support a service user to remain on a low dose of 
benzodiazepines with a view to further reduction if or when appropriate. 
42
43
44
11. Schedules, conversion table 
and detoxification
11.1 Detoxification guidelines for GPs
Decisions about dose and reduction should be made between the GP and the service 
user in a collaborative and flexible manner. Where rigid schedules are imposed, 
outcomes may be compromised.
Below are benzodizepine guideline schedules that may support doctors in planning a 
client-specific detoxification. 
11.2 Schedules
Detoxification schedule: Option 1
Reduction of one-eighth (between one-tenth and one-quarter) of the daily dose every 
fortnight.
Initially reduce by 2 – 2.5 mg and if withdrawal symptoms occur, then the dose can be 
maintained until symptoms improve.
High doses: Faster rate of reduction from high dose to therapeutic dose, for example by 
half over six weeks.
Source: Department of Health (England) and the devolved administrations (2007).
Detoxification schedule: Option 2
If daily dose is between 30 - 40mg reduce by 5mg fortnightly
If daily dose is between 20 - 30mg reduce by 2 - 5mg fortnightly
If daily dose is less than 20mg reduce by 2 mg fortnightly
When down to 5 mg reduce by 1 mg every 2 weeks. (Can use ½ of 2mg tablet or oral 
solution of diazepam 2mg / 5ml or 5mg / 5ml).
Recommended programme length approximately 6 months.
Source: Ford, Roberts & Barjolin (2005).
Detoxification schedule: Option 3
Replace the drug being used by equivalent doses of diazepam at the rate of one dose per 
day.
Reduce by 2mg if the daily dose is 15mg - 20mg
Reduce by 1mg if the daily dose is 10mg -15mg
Reduce by 0.5mg if the daily dose is 5mg
Tailor the dose reduction to patient response, i.e. weekly, fortnightly or monthly. Once 
patient is at a dosage of 0.5mg daily the dose interval can be increased to every two to 
three days.
Source: Benzodiazepine Committee (2002).
11.3 Conversion table
Diazepam is regarded as the first-line treatment for benzodiazepine detoxification due 
to its pharmacological profile which includes intermediate half-life, which is associated 
with reduced intensity of withdrawal symptoms. In exceptional circumstances, other 
benzodiazepines may be used for detoxification. However, caution should be exercised 
in using short-acting benzodiazepines as this can lead to incomplete cover and 
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complications such as withdrawal seizures.
Table 1 (Benzodiazepine Conversion Table) presents the approximate equivalent doses to 
10mg diazepam (Valium). Conversion tables vary throughout literature. The information  
provided on benzodiazepine conversion can differ between detoxing individuals. All of the 
drugs listed below are recommended for short-term use only (2-4 weeks maximum).
Benzodiazepines Approximate Equivalent 
Oral dosages to 10mg of 
Diazepam
Half-life (hrs)1
[active metabolite]
Alprazolam: (Xanax, Xanor, 
Tafil)
0.5
Bromazepam: (Lexotan, 
Lexomil)
5-6 10-20
Chlordiazepoxide: (Librium) 25 5-30 [36-200]
Clorazepate: (Tranxene) 15 [36-200]
Flunitrazepam: (Rohypnol) 1 18-26 [36-200]
Flurazepam: (Dalmane) 15-30 [40-250]
Lorazepam: (Ativan, Te-
mesta, Tavor)
1 10-20
Lormetazepam: (Noctamid) 1-2 10-12
Nitrazepam: (Mogadon) 10 15-38
Oxazepam: (Serax, Serenid, 
Serepax, Seresta)
20 4-15
Prazepam: (Centrax, Ly-
sanxia)
10-20 [36-200]
Temazepam: (Restoril, 
Normison, Euhypnos)
20 8-22
Triazolam: (Halcion) 0.5 2
Non-benzodiazepines with 
similar effects
Zaleplon: (Sonata) 20 2
Zolpidem: (Ambien, Stil-
noct, Stilnox)
20 2
Zopiclone: (Zimovane, 
Imovane)
15 5-6
Table 1. Benzodiazepine Conversion (Ashton, 2002)
See National Institute for Care and Health Excellence (2015) For examples of switching 
schedules and other information about conversion and reduction.
Time Frame for Detoxification
The pace at which a service user detoxifies should be decided on a case-by-case basis 
and should be informed by service user need, motivation to detox and goals.
Detoxification should be consistent and in response to service user substance tolerance, 
withdrawal symptoms and comfort of pace.
In general, literature promotes longer detoxification periods involving slow dose 
reduction; guidance is that detoxification schedules should be considered as a matter of 
months rather than of weeks.
Faster detoxification schedules can mean that the service user experiences 
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uncomfortable withdrawal symptoms due to dose reduction, fast withdrawal is also 
associated with relapse.
The minimum psychosocial supports outlined in these guidelines have been developed to 
support service users through longer detoxification. The guidelines are not suitable for 
detoxification under a shorter time frame (for example less than six weeks).
In rare circumstances GPs may agree to provide a shorter detoxification schedule to their 
patients. Where this occurs, more intensive psychosocial and medical supports should 
be in place. The principles of interagency work enshrined in these guidelines may be 
useful in the provision of such.
If a shorter detoxification schedule is pursued, the increased risk of heightened 
withdrawal symptoms, relapse and attendant risks should be explained to the service 
user by the key worker and GP. 
If a service user feels under pressure to complete a detoxification process in a faster 
time period than would be advised, for example in order to meet criteria for accessing 
a residential treatment facility, attempts should be made by the GP / key worker to 
negotiate a more suitable timeframe with the residential provider, and ensure that the 
detoxification is undertaken in as safe a manner as possible. 
11.4 Benzodiazepine withdrawal symptoms
Benzodiazepine withdrawal symptoms consist of both psychological and physical 
symptoms which an individual may experience during detoxification. Withdrawal 
symptoms increase in proportion to the length of time the benzodiazepines have been 
used and are worse when a high dose has been consumed. Drug withdrawal responses 
usually involve the re-emergence of the initial symptom for which the drug was taken. 
For benzodiazepine users this can mean feelings of anxiety and stress. The Community 
Detoxification Guidelines recommend a slow withdrawal schedule to reduce the 
possibility of severe withdrawal symptoms. Not every detoxing individual may experience 
withdrawal symptoms.
Psychological withdrawal symptoms:
• Excitability
• Insomnia, nightmares and sleep disturbance
• Increased anxiety, panic attacks
• Social phobia
• Depression
• Aggression
• Derealisation
• Depersonalisation
• Poor memory
• Poor concentration
• Obsessions
• Hallucinations
• Intrusive memories
• Paranoid thoughts
• Cravings
Physical withdrawal symptoms:
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• Fits
• Headache
• Sweating
• Pain and stiffness
• Fatigue
• Influenza-like symptoms
• Dizziness
• Palpitations
• Weight change
• Appetite change
• Skin rashes
• Hypersensitivity - touch, taste, sound, light
• Dry mouth
• Gastrointestinal symptoms – nausea vomiting, diarrhoea, difficulty swallowing
• Blurred/ double vision
• Over-breathing
Management for benzodiazepine withdrawal symptoms:
• Avoidance of tea, coffee and other stimulants near bed-time
• Drinking herbal teas
• Relaxation music – CD and phone apps
• Adopting anxiety management techniques
• Taking prescribed dose of benzodiazepine at night 
• Behavioural therapy – to replace the anxiety-related behaviours with better 
adapted ones
• Breathing techniques
• Guided imaging – focus on relaxing situations, relaxing music and calming words
• Role-play - experience controlled exposure to stressful and frightening situations
• CBT – individuals learn to understand their thinking patterns 
• Acupuncture 
• Massage
• Aromatherapy 
• Exercise – walking and anything experienced as enjoyable
• Yoga
• Meditation
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Appendix 1 
Initial meeting form
Key Worker Initial Checklist
The initial checklist must be completed by a key worker and service user at the first 
Community Detoxification meeting. The Checklist, Key Worker Assessment Form, Client 
Credentials Form and a Drug Diary must be completed before a GP is contacted. 
To ensure the best possible practice, staff should ensure that service users are fully 
informed of the Community Detoxification process. Below is a sample checklist and 
explanatory notes.
Sample Checklist:
1. Explaining Roles
Outline the role of the key worker and GP throughout the community detox process 
as well as what commitment is expected from the individual.
1.1 Key worker
1.2 GP 
1.3 Service user
2. The Community Detoxifiction Process 
Outline the different stages of a benzodiazepine community detoxification.
2.1 Preparation
2.2 GP assessment
2.3 Detox
2.4 Aftercare
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Appendix 2 
Risk information and participation agreement
To be filled out with key worker.
The purpose of this form is to give you information and ask you to sign an agreement on:
1. Risks during and after a Community Detoxification programme and information 
on how to manage such risks.
2. Your rights regarding confidentiality and sharing your information as needed for 
the detoxification programme.
3. Future contact regarding your experience of the detoxification programme.
RISKS
1. Methadone Detoxification Increases the risk of overdose
During and after your detoxification, your tolerance decreases. If you relapse you are 
at a much higher risk of overdose than when you were using methadone. If you inject 
during a relapse, you are at a much higher risk of fatal overdose than if you smoke. 
When compared to those who stay on methadone, people who detoxify are more likely to 
relapse and thus more likely to overdose or become infected with HIV, Hepatitis B or C in 
the future. 
2. Benzodiazepine / benzodiazepine-like drug detoxification increases the risk of 
overdose and seizures
Where benzodiazepine use is stopped suddenly, there is an increased risk of seizures 
occurring. The safest way to undertake the benzodiazepine detoxification process is by 
means of gradual dose reduction under medical supervision.
3. Poly drug use increases the risk of overdose
The use of any drug carries a risk of overdose. This risk is greatly increased when 
certain drugs are used in combination, particularly opiates (codeine, heroin, methadone), 
benzodiazepines, tranquillizers, sleeping tablets, anti-depressants and alcohol
4. Sharing injecting or snorting equipment increases your risk of acquiring HIV and 
other blood-born viruses
When you detoxify, you may no longer carry your own works or other equipment with you. 
If you relapse you may be at a higher risk of having to share equipment than when you 
were using regularly.
Other things to plan for during and after Detoxification
 
Cravings
Craving for drugs can last for a while or can be experienced unexpectedly. Through 
relapse prevention, your key worker will help you plan to deal with expected and 
unexpected cravings.
Stress
Often people who have used drugs for a number of years respond to stressful situations 
by taking drugs. Your key worker will help you to develop and strengthen your coping 
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skills to handle difficult situations and life stresses without drugs. Some people attend 
counselling or a support group etc to look at these issues. 
Confidence after you finish
When you finish a detoxification programme you are still at serious risk of relapse. Often 
this can be the most difficult time for people. Developing and following an aftercare plan 
with your key worker, which includes care plan supports and relapse prevention can help 
you to move on safely and manage risk after you finish the detoxification process.
People around you
Hopefully, while most people around you will be a source of support, some people in your 
life may not be. Your key worker can help you to plan how to deal with these issues.
Loneliness
Significant lifestyle changes can mean that people feel isolated or lonely. An important 
part of your care planning can be to work with your key worker in finding meaningful 
ways to fill the spaces in your day and build new social networks.
Your key worker will talk to you about all of these issues and any other concerns you have 
regarding relapse. Together you will come up with a relapse prevention / aftercare plan.
Community Detoxification Service User Participation Agreement
To make sure that you have the best chance of a successful detoxification and that you 
reduce the risk of relapse, your commitment to this Community Detoxification involves:
1. Ensuring you understand the risks involved in undergoing a Community 
Detoxification Programme.
2. Setting realistic goals for reduction/detoxification.
3. Adhering to your detoxification schedule and working on your care plan.
4. Keeping your scheduled appointments with your doctor and key worker.
5. Telling your key worker and your GP as soon as possible if any issues arise or if 
you relapse. This is so you can work together through your care plan to manage 
any difficulties. Sharing information and keeping everyone up-to-date can help 
prevent relapse and overdose.
6. Continuing through 6 months of care-planning and relapse prevention after you 
finish
7. Signing this form to give permission for people involved in your detoxification plan 
to pass on information to each other, and to confirm that you understand the risks 
involved in undertaking a Community Detoxification programme.
I have read this information sheet (or the sheet has been read to me) and I understand the 
information as outlined above.
Signature of service user: _______________________________________________
Date of signing this agreement: _______________________________________________
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Appendix 3 
Key Work Assessment Form
Service user name: ______________________________________________________
Phone number:  ______________________________________________________
Email address:   ______________________________________________________
Postal address:   ______________________________________________________
  
   ______________________________________________________
   ______________________________________________________
It is required that the Key Work Assessment Form is completed at the initial meeting 
between the person delivering psychosocial support and the service user. This meeting 
should be scheduled before the service user presents to the GP for an assessment. 
The key worker is required to deliver the initial assessment form to the GP in person 
or via email. The purpose of the Key Work Assessment Form is to assist the GP in 
establishing any medical contraindications that may be present to preclude a service 
user from Community Detoxification. 
Section 1 Drug Use
Please record what substance(s) the service user is consuming and in what quantities.
 Substance Weekly consumption
Alcohol
Alcohol-based solution
Marijuana
Benzodiazepines (prescribed and non-prescribed)
Z Hypnotics (prescribed and non-prescribed)
Methadone (prescribed and non-prescribed)
Heroin
Codeine 
Amphetamines
Methamphetamines
MDMA
Mephedrone (snowblow)
Crack Cocaine
Cocaine
Anti-Depressants
Other
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Detoxification History
Date/year Treatment service Did the individual complete the treat-
ment?
Does the service user have a history of fits or severe withdrawal symptoms in treatment?
Yes No
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Section 2 Mental Health
Is the individual experiencing any of the following?
 Depression     Visions
 Hearing voices    Anxiety
 Racing thoughts    Suicidal thoughts
 Fast speech     Detachment from reality
 Confused thinking    Paranoia
 Mood changes    Hallucinations
 Unusual behaviour    Abnormal speech
 Ideas of self-harm    Ideas of harming others
 Poverty of speech    Over-activity 
Other: _____________________________________________________________________
___________________________________________________________________________
Is the individual currently attending a professional for mental health purposes? 
___________________________________________________________________________
___________________________________________________________________________
If yes, please include the name and contact details of this professional: 
___________________________________________________________________________
___________________________________________________________________________
Is this individual currently on prescribed medication for mental health purposes?
___________________________________________________________________________
___________________________________________________________________________
Please give a brief history of the service user’s mental health (this is to include 
treatment, medication, diagnosis, self-harm, suicide:
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
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Section 3 Physical Health
Has the individual any known physical illness or disease? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
Is he or she on medication for physical health purposes?
 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
Section 4 Environment
What is the service users living arrangement? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
If he or she is currently residing in a hostel, how long is this arrangement likely to 
continue?
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
Signatures
Date  ______________________________________________________________________
Key worker signature  ________________________________________________________
Service user signature________________________________________________________
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Appendix 4
Treatment Outcomes Profile (TOP) for 
Community Detoxification
The Treatment Outcomes Profile (TOP) form examines an individual’s drug use, health 
and social functioning over a 28 day period. It is recommended that this form is 
completed periodically throughout the preparation, detoxification and aftercare stages of 
the community detoxification process.
Date:
Service user name:   _________________________________________________________
Key worker name:     _________________________________________________________
Treatment Stage:    Preparation  
    Detoxification    
                                                                  Aftercare 
Section 1: Substance use
Record the average amount on a using day and number of days on which substance used 
in each of the past four weeks.
Substance
Measurement Average daily
Week 
4
Week 
3
Week 
2
Week 
1
Total 
Days
Days 
(0-7)
Days 
(0-7)
Days 
(0-7)
Days 
(0-7) (0-28)
Alcohol Standard drinks
Heroin grams
Methadone (prescribed) mls
Methadone (non-prescribed) mls
Crack/cocaine grams
Amphetamines / Headshop grams
Cannabis spliffs
Ecstasy tablets
Benzodiazepines (prescribed) tablets
Benzodiazepines (non-pre-
scribed) tablets
Other sedatives (zimmovanes etc) tablets
LSD / Acid tabs
Other:
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Section 2: Injecting risk behaviour 
Record the number of days client injected non-prescribed drugs in the past four weeks (if 
no, enter zero and proceed to section 3)
Week 4 Week 3 Week 2 Week 1
a) Number of days injected
b) Times injected per day
Please tick if at any point in the past four weeks the client has:
c) Injected with needle or syringe used by someone else  
d) Injected using a spoon, water or filter used by someone else 
Section 3: Health and social functioning
a) Client’s rating of psychological health status (e.g. anxiety, depression and problem 
emotions and feelings)
b) Client’s rating of physical health status (e.g. extent of physical symptoms and being 
troubled by illness)
c) Record accommodation issues for the past 30 days
 Acute Housing Problem  yes  no 
 At risk of eviction  yes  no 
d) Client’s rating of overall quality of life (e.g. able to enjoy life, gets on well with family and 
partner)
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